<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39443934</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6831</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>23</Day></PubDate></JournalIssue><Title>BMC oral health</Title><ISOAbbreviation>BMC Oral Health</ISOAbbreviation></Journal><ArticleTitle>Oral complications during the two waves of COVID-19 pandemic in China: a prospective cross-section analysis of 510 cases using questionnaire.</ArticleTitle><Pagination><StartPage>1265</StartPage><MedlinePgn>1265</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1265</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12903-024-05058-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Oral complications such as parageusia, xerostomia, and oral ulcers are frequently observed in patients with COVID-19. The aim of this study was to understand the oral complications and their influencing factors during the two waves of the COVID-19 pandemic in China between December 2022 and May 2023.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 347 patients during the COVID-19 pandemic from December 2022 and January 2023 and 163 patients during the second COVID-19 pandemic were recruited through the Disease Prevention and Control Reporting System. Data on oral complications were collected via researcher-made questionnaires.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During both pandemic periods, more than 50% of the subjects developed oral complications. Specifically, the incidence of parageusia, pathological tongue coating, and xerostomia all exceeded 20%, while the incidence of oral ulcers surpassed 7%. Patients with allotriosmia and xerostomia had a significantly higher likelihood of developing other oral complications. Hospitalized patients requiring supplemental oxygen had a significantly higher incidence of oral complications.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results of our study underline that oral complications during the COVID-19 pandemic are prevalent, and their incidence has not decreased during the subsequent pandemic. In the context of the ongoing global spread of COVID-19, this study lays the foundation for physicians in recognizing and managing oral complications, which will improve the oral health of communities globally.</AbstractText><CopyrightInformation>Â© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Qu</LastName><ForeName>Bojing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral &amp; Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral medicine, School of Stomatology, Xi'an, 710032, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Honglin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral &amp; Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral medicine, School of Stomatology, Xi'an, 710032, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Wanli</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral &amp; Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral medicine, School of Stomatology, Xi'an, 710032, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Minghui</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral &amp; Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral medicine, School of Stomatology, Xi'an, 710032, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Pathogen Biology, School of Basic Medical Sciences, Fourth Military Medical University, Xi'an, 710032, Shaanxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral &amp; Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral medicine, School of Stomatology, Xi'an, 710032, Shaanxi, China. liuqing@fmmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oral medicine, School of Stomatology, the Fourth Military Medical University, Xi'an, 710032, Shaanxi Province, P. R. China. liuqing@fmmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Zhenlai</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral &amp; Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral medicine, School of Stomatology, Xi'an, 710032, Shaanxi, China. zhuzhenlai@fmmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology &amp; Pathogen Biology, School of Basic Medical Sciences, Fourth Military Medical University, Xi'an, 710032, Shaanxi, China. zhuzhenlai@fmmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shaanxi, China. zhuzhenlai@fmmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oral medicine, School of Stomatology, the Fourth Military Medical University, Xi'an, 710032, Shaanxi Province, P. R. China. zhuzhenlai@fmmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020SF-015</GrantID><Agency>the Key Research and Development Program of Shaanxi</Agency><Country /></Grant><Grant><GrantID>82203925</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>2024JC-YBMS-645</GrantID><Agency>the Natural Science Foundation of Shaanxi Province</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Oral Health</MedlineTA><NlmUniqueID>101088684</NlmUniqueID><ISSNLinking>1472-6831</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014987" MajorTopicYN="Y">Xerostomia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019226" MajorTopicYN="N">Oral Ulcer</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009059" MajorTopicYN="N">Mouth Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Oral complications</Keyword><Keyword MajorTopicYN="N">Oral ulcer</Keyword><Keyword MajorTopicYN="N">Parageusia</Keyword><Keyword MajorTopicYN="N">Questionnaire</Keyword><Keyword MajorTopicYN="N">Xerostomia</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>0</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39443934</ArticleId><ArticleId IdType="doi">10.1186/s12903-024-05058-z</ArticleId><ArticleId IdType="pii">10.1186/s12903-024-05058-z</ArticleId><ArticleId IdType="pmc">PMC11515644</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Panahi Y, Gorabi AM, Talaei S, Beiraghdar F, Akbarzadeh A, Tarhriz V, Mellatyar H. An overview on the treatments and Prevention Against Covid-19. VIROL J. 2023;20:23. 10.1186/s12985-023-01973-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9906607</ArticleId><ArticleId IdType="pubmed">36755327</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian D, Nie W, Sun Y, Ye Q. The epidemiological features of the SARS-Cov-2 Omicron Subvariant Ba.5 and its evasion of the neutralizing activity of vaccination and prior infection. VACCINES-BASEL. 2022;10. 10.3390/vaccines10101699.</Citation></Reference><Reference><Citation>Chatterjee S, Bhattacharya M, Nag S, Dhama K, Chakraborty C. A detailed overview of SARS-Cov-2 Omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, Immunological Landscape, Immune escape, and therapies. VIRUSES-BASEL. 2023;15. 10.3390/v15010167.</Citation></Reference><Reference><Citation>Farid H, Khan M, Jamal S, Ghafoor R. Oral manifestations of Covid-19-a literature review. REV MED VIROL. 2022;32:e2248. 10.1002/rmv.2248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209937</ArticleId><ArticleId IdType="pubmed">34028129</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira AR. Oral manifestations in Coronavirus Disease 2019 (Covid-19). ORAL DIS 2021; 27 Suppl 3:770. 10.1111/odi.13463</Citation></Reference><Reference><Citation>Luers JC, Rokohl AC, Loreck N, Wawer MP, Augustin M, Dewald F, Klein F, Lehmann C, Heindl LM. Olfactory and gustatory dysfunction in Coronavirus Disease 2019 (Covid-19). CLIN INFECT DIS. 2020;71:2262â4. 10.1093/cid/ciaa525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197599</ArticleId><ArticleId IdType="pubmed">32357210</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu C, Cui C, Hautefort C, et al. Olfactory and gustatory dysfunction as an early identifier of Covid-19 in adults and children: an International Multicenter Study. OTOLARYNG HEAD NECK. 2020;163:714â21. 10.1177/0194599820934376.</Citation></Reference><Reference><Citation>Saraf S, Nalawade T, Mallikarjuna R, Al KA. The Retrospective Pilot Study of the prevalence of olfactory dysfunction or loss of Smell, loss of taste and oral manifestations among Covid-19 Positive Health Workers in Muscat, Oman. INDIAN J OTOLARYNGOL. 2023;75:742â6. 10.1007/s12070-022-03293-w.</Citation></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, De Siati DR, OTO-RHINO, -L. 2020; 277:2251â61. doi:10.1007/s00405-020-05965-1.</Citation></Reference><Reference><Citation>Chiesa-Estomba CM, Lechien JR, Portillo-Mazal P, Martinez F, Cuauro-Sanchez J, Calvo-Henriquez C, Saussez S. Olfactory and gustatory dysfunctions in Covid-19. First reports of latin-american ethnic patients. AM J OTOLARYNG. 2020;41:102605. 10.1016/j.amjoto.2020.102605.</Citation></Reference><Reference><Citation>Al-Magsoosi M, Al-Asadi O, Al-Quraine NT, Sami SM, Haider J. Oral Manifestations Associated with Covid-19 Infection: A Cross-Sectional Study of Recovered Iraqi Patients. INT J DENT. 2023; 2023:4288182. 10.1155/2023/4288182</Citation></Reference><Reference><Citation>Binmadi NO, Aljohani S, Alsharif MT, Almazrooa SA, Sindi AM. Oral Manifestations of Covid-19: A Cross-Sectional Study of their Prevalence and Association with Disease Severity. J CLIN MED. 2022; 11. 10.3390/jcm11154461</Citation></Reference><Reference><Citation>Farshidfar N, Hamedani S. Hyposalivation as a potential risk for SARS-Cov-2 infection: inhibitory role of Saliva. ORAL DIS. 2021;27(Suppl 3):750â1. 10.1111/odi.13375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267261</ArticleId><ArticleId IdType="pubmed">32348636</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchiya H. Characterization and Pathogenic Speculation of Xerostomia Associated with Covid-19: a narrative review. DENT J-BASEL. 2021;9. 10.3390/dj9110130.</Citation></Reference><Reference><Citation>Gherlone EF, Polizzi E, Tete G, De Lorenzo R, Magnaghi C, Rovere QP, Ciceri F. Frequent and persistent salivary gland ectasia and oral Disease after Covid-19. J DENT RES. 2021;100:464â71. 10.1177/0022034521997112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930603</ArticleId><ArticleId IdType="pubmed">33655804</ArticleId></ArticleIdList></Reference><Reference><Citation>Fantozzi PJ, Pampena E, Di Vanna D, et al. Xerostomia, Gustatory and olfactory dysfunctions in patients with Covid-19. AM J OTOLARYNG. 2020;41:102721. 10.1016/j.amjoto.2020.102721.</Citation></Reference><Reference><Citation>Chen L, Zhao J, Peng J, et al. Detection of SARS-Cov-2 in saliva and characterization of oral symptoms in Covid-19 patients. CELL PROLIFERAT. 2020;53:e12923. 10.1111/cpr.12923.</Citation></Reference><Reference><Citation>Biadsee A, Biadsee A, Kassem F, Dagan O, Masarwa S, Ormianer Z. Olfactory and oral manifestations of Covid-19: sex-related Symptoms-a potential pathway to early diagnosis. OTOLARYNG HEAD NECK. 2020;163:722â8. 10.1177/0194599820934380.</Citation></Reference><Reference><Citation>Jacob LE, Krishnan M, Mathew A, Mathew AL, Baby TK, Krishnan A. Xerostomia - A Comprehensive Review with a Focus on Mid-life Health. J MID-LIFE HEALTH. 2022;13:100â6. 10.4103/jmh.jmh_91_21.</Citation></Reference><Reference><Citation>Sedighi L, Khari S, Hasheminik M, Salimi Akinabadi A, Alipour H, Shafigh E, Shafigh N. The Effect of Artificial Saliva on the control of Dry Mouth: a Semi-experimental Study on Covid-19 patients under non-invasive mechanical ventilation. BMC Oral Health. 2024;24:610â43. 10.1186/s12903-024-04386-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11129428</ArticleId><ArticleId IdType="pubmed">38797824</ArticleId></ArticleIdList></Reference><Reference><Citation>Favia G, Barile G, Tempesta A, et al. Relationship between oral lesions and severe SARS-Cov-2 infection in Intensive Care Unit patients. ORAL DIS. 2024;30:1296â303. 10.1111/odi.14515.</Citation><ArticleIdList><ArticleId IdType="pubmed">36680407</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Xie Y, Li C. Understanding the mechanisms for Covid-19 Vaccineâs Protection Against infection and severe disease. EXPERT REV VACCINES. 2023;22:186â92. 10.1080/14760584.2023.2174529.</Citation><ArticleIdList><ArticleId IdType="pubmed">36715150</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong J, Liu S, Cui T, Li J, Zhu F, Zhong N, Huang W, Zhao Z, Wang Z. Heterologous booster with inhaled Adenovirus Vector Covid-19 Vaccine Generated more neutralizing antibodies against different SARS-Cov-2 variants. EMERG MICROBES INFEC. 2022;11:2689â97. 10.1080/22221751.2022.2132881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9639505</ArticleId><ArticleId IdType="pubmed">36197655</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Xu Y, Xie Y, et al. Protective effect of plasma neutralization from prior SARS-Cov-2 Omicron Infection against Ba.5 Subvariant symptomatic reinfection. LANCET REG HEALTH-W. 2023;33:100758. 10.1016/j.lanwpc.2023.100758.</Citation></Reference><Reference><Citation>Favia G, Tempesta A, Barile G, et al. Covid-19 symptomatic patients with oral lesions: clinical and histopathological study on 123 cases of the University Hospital Policlinic of Bari with a purpose of a new classification. J CLIN MED. 2021;10:757. 10.3390/jcm10040757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7918830</ArticleId><ArticleId IdType="pubmed">33668602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kot WY, Li JW, Chan A, Zheng LW. A reflection on Covid-19 and oral mucosal lesion: a systematic review. Front Oral Health. 2023;4:1322458. 10.3389/froh.2023.1322458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10759230</ArticleId><ArticleId IdType="pubmed">38169876</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Gao J, Holden A, Nanayakkara S. Perceptions and attitudes of Dental Practitioners towards impacts of Covid-19 andemic on clinical Dentistry: a cross-sectional study. BMC Oral Health. 2022;22:424. 10.1186/s12903-022-02457-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9502939</ArticleId><ArticleId IdType="pubmed">36138429</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>